Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Soleno Therapeutics Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +2 vs. Q4 2021
- Shares held
- 50.7M
- +21.8M (+75.7%) vs. Q4 2021
- Total value
- $11.2M
- −$577.5K (−4.9%) vs. Q4 2021
- New holders
- 7
- 10 more added
- Sold out
- 5
- 13 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 227 | $2.09B |
| Q4 2025 | 248 | $3.01B |
| Q3 2025 | 240 | $4.41B |
| Q2 2025 | 234 | $4.75B |
| Q1 2025 | 217 | $3.90B |
| Q4 2024 | 166 | $2.29B |
| Q3 2024 | 142 | $2.38B |
| Q2 2024 | 114 | $1.79B |
| Q1 2024 | 98 | $1.52B |
| Q4 2023 | 76 | $1.26B |
| Q3 2023 | 54 | $598.8M |
| Q2 2023 | 23 | $21.8M |
| Q1 2023 | 21 | $7.06M |
| Q4 2022 | 26 | $6.00M |
| Q3 2022 | 22 | $5.23M |
| Q2 2022 | 40 | $8.80M |
| Q1 2022 | 41 | $11.2M |
| Q4 2021 | 39 | $11.8M |
| Q3 2021 | 39 | $27.1M |
| Q2 2021 | 47 | $33.6M |
| Q1 2021 | 63 | $41.2M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Soleno Therapeutics Inc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bray Capital Advisors | 2,000 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,601 | $0 | 0.00% | +1,507+1,603.2% | Added |
| Wells Fargo & Company | 349 | $0 | 0.00% | +2+0.6% | Added |
| Morgan Stanley | 43 | $0 | 0.00% | −279−86.6% | Reduced |
| Royal Bank of Canada | 137 | $0 | 0.00% | −145−51.4% | Reduced |
| Cutler Group LP | 1,100 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 156 | $0 | 0.00% | +156 | New |
| Advisor Group Holdings, Inc. | 3,040 | $767 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 10,048 | $2.00K | 0.00% | −33,893−77.1% | Reduced |
| Avantax Planning Partners, Inc. | 10,700 | $2.00K | 0.00% | 00.0% | Unchanged |
| Levy Wealth Management Group, LLC | 10,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,433 | $2.00K | 0.00% | +2,647+55.3% | Added |
| Susquehanna International Group, LLP | 14,677 | $3.00K | 0.00% | −122,066−89.3% | Reduced |
| Jane Street Group, LLC | 13,998 | $3.00K | 0.00% | −5,922−29.7% | Reduced |
| Victory Capital Management Inc | 13,387 | $3.00K | 0.00% | +13,387 | New |
| Aspiriant, LLC | 17,295 | $4.00K | 0.00% | 00.0% | Unchanged |
| Warberg Asset Management LLC | 27,000 | $6.00K | 0.00% | +27,000 | New |
| Bollard Group LLC | 34,322 | $8.00K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 42,270 | $9.00K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 100,000 | $22.0K | 0.00% | +100,000 | New |
| Northern Trust Corp | 105,481 | $24.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 130,317 | $29.0K | 0.00% | −6,021−4.4% | Reduced |
| Ikarian Capital, LLC | 128,454 | $29.0K | 0.01% | +6,760+5.6% | Added |
| BNP Paribas Arbitrage, SA | 140,018 | $31.2K | 0.00% | −171−0.1% | Reduced |
| Citadel Advisors LLC | 144,623 | $32.0K | 0.00% | −5,253−3.5% | Reduced |
| Two Sigma Investments, LP | 208,546 | $47.0K | 0.00% | −101,000−32.6% | Reduced |
| Oppenheimer & Co Inc | 232,070 | $52.0K | 0.00% | −68,799−22.9% | Reduced |
| State Street Corp | 231,741 | $52.0K | 0.00% | +11,641+5.3% | Added |
| Two Sigma Advisers, LP | 246,400 | $55.0K | 0.00% | −151,600−38.1% | Reduced |
| Renaissance Technologies LLC | 248,200 | $55.0K | 0.00% | +187,600+309.6% | Added |
| Boothbay Fund Management, LLC | 252,154 | $56.0K | 0.00% | +240,000+1,974.7% | Added |
| Geode Capital Management, LLC | 430,253 | $95.0K | 0.00% | 00.0% | Unchanged |
| Empery Asset Management, LP | 1,401,400 | $313.0K | 1.47% | +1,401,400 | New |
| Worth Venture Partners, LLC | 1,691,840 | $377.0K | 0.18% | +1,691,840 | New |
| Vanguard Group Inc | 2,051,851 | $457.0K | 0.00% | −12,541−0.6% | Reduced |
| Oracle Investment Management Inc | 2,132,000 | $475.0K | 0.10% | 00.0% | Unchanged |
| Granite Point Capital Management, L.P. | 2,646,850 | $590.0K | 0.30% | +1,800,000+212.6% | Added |
| Birchview Capital, LP | 3,676,899 | $820.0K | 0.59% | +2,800,000+319.3% | Added |
| AIGH Capital Management LLC | 6,800,000 | $1.52M | 0.55% | +6,800,000 | New |
| Nantahala Capital Management, LLC | 9,436,512 | $2.10M | 0.15% | −328,617−3.4% | Reduced |
| Abingworth LLP | 18,022,602 | $3.96M | 1.12% | +7,720,000+74.9% | Added |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −67,326−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −30,211−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −23,628−100.0% | Sold out |
| Migdal Insurance & Financial Holdings Ltd. | 0 | $0 | 0.00% | −9,873−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −107−100.0% | Sold out |